Abstract
This project aimed to investigate whether the overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium (RPE), induced by recombinant adenovirus mediated delivery of VEGF164, is sufficient to initiate the development of leaky choroidal blood vessels in a rat model. Eyes of pigmented rats were subjected to krypton laser photocoagulation or subretinal injection with recombinant adenovirus constructs Ad.RSV.VEGF or Ad.CMV.VEGF. Initially the animals were examined with fundus photography followed by fluorescein angiography. Retinal photographs demonstrated that the krypton laser produced moderate burns and that the subretinal injection resulted in the formation of a bleb in the subretinal space. Injection of control recombinant adenovirus Ad. RSV.βgal resulted in the expression of βgal reporter gene in the RPE layer. Of the 141 laser spots delivered into a total of 17 rat eyes, 52.4% developed fluorescein leakage that was detectable by angiography. Of seven eyes injected with Ad.RSV.VEGF, 5 developed leakage at 2 weeks post injection, and of 8 eyes which were injected with Ad.CMV.VEGF, 5 developed leakage at 1 week post injection. However, the development of leaky blood vessels was temporary and both Ad.RSV.VEGF and Ad.CMV.VEGF injected animals showed regression of leaky vessels by 4 and 5 weeks post injection, respectively. These results suggest that the upregulation of VEGF in the RPE layer may be a key factor in the series of events leading to the development of CNV.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
W.R. Green and D.J. Wilson, 1986, Choroidal neovascularization, Ophthalmology 93:1169–1176.
S.H. Sarks, 1973, New vessel formation beneath the retinal pigment epithelium in senile eyes, Br J Ophthalmol 57:951–965.
W.R. Green, C. Enger, 1993, Age-related macular degeneration histopathologic studies. The 1993 Lorenz E. Zimmerman Lecture. Ophthalmology 100:1519–1535.
N.M. Bressler, J.C. Silva, S.B. Bressler, S.L. Fine, and W.R. Green, 1994, Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina 14(2):130–142.
S.H. Sarks, 1976, Ageing and degeneration in the macular region: a clinico-pathological study, Br J Ophthalmol 60:324–341.
S.H. Sarks, D. van Driel, L. Maxwell, and M.C. Killingsworth, 1980, Softening of drusen and subretinal neovascularization, Trans Ophthalmol Soc UK 100:414–422.
W.J. Heriot, P. Henkind, R.W. Bellhorn, and M.S. Burns, 1984, Choroidal neovascularization can digest Bruch’s membrane—A prior break is not essential, Ophthalmology 91(12):1603–1608.
A. Pollack, W.J. Heriot, and P. Henkind, 1986, Celluar processes causing defects in Bruch’s membrance following krypton laser photocoagulation, Ophthalmology 93:1113–1119.
R.N. Frank, A. Das, and M.L. Weber, 1989, A model of subretinal neovascularization in the pigmented rat, Curr Eye Res 8:239–247.
X Yi, N Ogata, M. Komada, K Takahashi, K. Omori,and M. Uyama, 1997, Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefe’s Arch Clin Exp Ophthalmol:313–319.
T. Ishibashi, Y. Hata, H. Yoshikawa, K. Nakagawa, K. Sueishi, and H. Inomata, 1997, Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefe’s Arch Clin Exp Ophthalmol 235:159–167.
E.T. Dobi, C.A. Puliafito, and M. Destro, 1989, A new model of experimental choroidal neovascularization in the rat, Arch Ophthalmol 107:264–269.
L. Feeney-Burns, C. Gao, and E.R. Berman, 1988, The fate of immunoreactive opsin following phagocytosis by pigment epithelium in human and monkey retinas, Invest Ophthalmol Vis Sci 29:708–719.
W. Shen, M. Yu, C. Barry, I.J. Constable, and P.E. Rakoczy, 1998, Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat, Br J Ophthalmol 82—in press
M.C. Killingsworth, S.H. Sarks, 1982, Giant cells in disciform macular degeneration of the human eye, Micron 13(3):359–360.
S.H. Sarks, P.L. Penfold, M.C. Killingsworth, and D. van Driel, 1985, Patterns in Macular Degeneration, in: Retinal Diseases, (S.J. Ryan, A.K. Dawson, eds.) pp. 87–93, Grune & Stratton. Inc. NY.
P.L. Penfold, M.C. Killingsworth, and S.H. Sarks, 1985, Senile macular degeneration: The involvement of immunocompetent cells, Graefe’s Arch Clin Exp Ophthalmol 223:69–76.
N. Ferrara, T. Davis-Smyth, 1997, The biology of vascular endothelial growth factor, Endocr Rev 18(1):4–25.
D.W. Leung, G. Cachianes, W. Kuang, D.V. Goeddel, and N. Ferrara, 1989, Vascular endothelial growth factor is a secreted angiogenic mitogen, Science 246:1306–1309.
H.F. Dvorak, L.F. Brown, M. Detmar, and A.M. Dvorak. 1995, Vascular permeanility factor vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029–1039.
A. Minchenko, T. Bauer, S. Salceda, and J. Caro, 1994, Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo, Lab Invest 71:374–379.
R.J. D’ Amato, A.P. Adamis, 1995, Angiogenesis inhibition in age-related macular degeneration, Ophthalmology 102:1261–1262.
P.A. D’Amore, 1994, Mechanisms of Retinal and Choroidal neovascularization, Invest Ophthalmol Vis Sci 35:3974–3979.
H.P. Heidenkummer, 1991, Age-related macular degeneration: current aspects of pathogenesis and treatment, Eye Science 7:6–20.
P.E. Rakoczy, C.M. Lai, M. Baines, S. Di Grandi, J.H. Fitton, and I.J. Constable, 1997, Modulation of cathepsin D activity in retinal pigment epithelial cells, Biochem J 324:935–940.
W.R. Green. 1985, Pathology of the macula, in: Ophthalmic Pathology, Volume 2 (W.H. Spencer, ed.) pp. 924–1034, W.B. Saunders Company.
S.O. Sykes, N.M. Bressler, M.G. Maguire, and A.P. Schachat, 1994, Detecting recurrent chorodial neovascularization comparison of clinical examination with and without fluorescein angiography, Arch Ophthalmol 112(12):1561–1566.
L. da Cruz, P. Rakoczy, M. Perricaudet, and I. Constable, 1996, Dynamics of gene transfer to retinal pigment epithelium, Invest Ophthalmol Vis Sci 37(12):2447–2454.
T.C. Becker, R.J. Noel, W.S. Coats, A.M. Gomez-Foix,T. Alam, R.D. Gerard, and C.B. Newgard, 1994, Use of recombinant adenovirus for metabolic engineering of mammalian cells, in: Methods in Cell Biology, Volume 43 pp. 161–189, Academic Press.
W. Zhang, P.E. Koch, and J.A. Roth, 1995, Detection of wild-type contamination in a recombinant adenoviral preparation by PCR, Biotechniques 18:444–446.
A.C. Bird, N.M. Bressler, S.B. Bressler, I.H. Chisholm, G. Coscas, and M.D. David, 1995, An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 39(5):367–374.
S.J. Ryan. 1989, Subretinal neovascularization, in: Retina, (S.J. Ryan, E.J. Murray, and Patz, eds.) pp. 107–125, Mosby, St Louis.
R.N. Frank, R.H. Amin, D. Eliott, J.E. Puklin, and G.W. Abrams, 1996, Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes, Am J Ophthalmol 122:393–403.
R.N. Frank, 1997, Growth factors in age-related macular degeneration:pathogenic and therapeutic implications, Ophthalmic Research 29:341–353.
P.F. Lopez, B.D. Sippy, H.M. Lambert, A.B. Thach, and D.R. Hinton, 1996, Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes, Invest Ophthalmol Vis Sci 37:855–868.
A. Kvanta, P.V. Algvere, L. Berglin, and S. Seregard, 1996, Subfoveal fibrovascular membranes in Age-related macular degeneration express vascular endothelial growth factor, Invest Ophthalmol Vis Sci 37(9):1929–1934.
G.A. Lutty, D.S. McLeod, C. Merges, A. Diggs, and J. Plouet, 1996, Localization of Vascular Endothelial Growth Factor in Human Retina and Choroid, Arch Ophthalmol 114:971–977.
N.C. Tsang, P.L. Penfold, P.J. Snitch, and F. Billson, 1992, Serum levels of antioxidants and age-related macular degeneration. Documenta Ophthalmologica 81(4):387–400.
B. Martini, S.J. Ryan, 1992, Argon laser lesion of the retina: occurrence and origin of macrophages. Euro J Ophthalmol 2:51–57.
X. Yi, K. Takahashi, N. Ogata, and M. Uyama, 1996, Immunohischemical proof of origin of macrophages in laser photocoagulation lesion in the retina. Jpn J Ophthalmol 40:192–201.
H. Kimura, T. Sakamoto, C. Spee, and et al. 1995, A new model for experimental subretinal neovascularisation in the rabbit, Invest Ophthalmol Vis Sci 35:3429–3435.
N. Ogata, M. Matsushima, Y. Takada, T. Tobe, and et al. 1996, Expression of basic fibroblast growth factor mRNA in developing choroidal neovascularization, Curr Eye Res:1008–1018.
H.G.T. Blaauwgeers, G.M. Holtkamp, P. Koolwijk, van Hinsbergh, V.M. Kroon, A. Kijistra, and R. Schlingemann, 1998, Preferential basal secretion of VEGF by RPE in vitro and expression of its receptor KDR on the inner choriocapillaris in vitro suggest a trophic relation in the normal eye, Invest Ophthalmol Vis Sci 39(4):S372
L. da Cruz, P. Rakoczy, M, Perricaudet, and I.J. Constable, 1996, The dynamics of gene transfer to retinal pigment epithelium. Invest Opthalmol Vis Sci 37(12):2447–2454.
M.B. Reichel, R.R. Ali, A.J. Thrasher, D.M. Hunt, S.S. Bhattacharya, and D. Baker, 1998, Immune responses limit adenovirally medited gene expression in the adult mouse eye, Gene Therapy 5:1038–1046.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Kluwer Academic / Plenum Publishers
About this chapter
Cite this chapter
Rakoczy, P.E. et al. (1999). Development Of Rat Models For Choroidal Neovascularisation (CNV). In: Hollyfield, J.G., Anderson, R.E., LaVail, M.M. (eds) Retinal Degenerative Diseases and Experimental Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-33172-0_36
Download citation
DOI: https://doi.org/10.1007/978-0-585-33172-0_36
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46193-4
Online ISBN: 978-0-585-33172-0
eBook Packages: Springer Book Archive